Virtual Intensive Outpatient Program for Alcoholism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a virtual intensive outpatient program to determine its effectiveness for individuals with moderate to severe alcohol use disorder. The program replicates the structure and support of a residential treatment program but operates entirely online over four weeks. Participants engage in daily group therapy, weekly one-on-one therapy, and medication management, with daily breathalyzer checks to monitor progress. This trial may suit individuals who consume more than 10 drinks a week (for women) or 15 drinks a week (for men), wish to stop drinking during the study, and can attend online sessions from home. As an unphased trial, this study provides a unique opportunity to explore innovative treatment options from the comfort of home.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this virtual intensive outpatient program is safe for participants?
Research has shown that intensive outpatient programs (IOPs) effectively treat alcohol and drug use problems. For many, they work just as well as inpatient care, allowing individuals to receive help without staying overnight in a clinic. Instead, therapy sessions can be attended from home.
IOPs are generally manageable for participants, with most experiencing success without significant issues. While any treatment may have side effects, IOPs are designed to ensure participant safety. They include regular therapy sessions and check-ins to monitor progress.
In virtual IOPs, participants receive support through online therapy, which includes group and individual sessions. This online format allows individuals to receive treatment from home, making the program accessible and convenient without compromising effectiveness.
Overall, IOPs, including virtual ones, have a strong record of safety and effectiveness. They provide a structured way to help individuals with alcohol use problems recover in a supportive environment.12345Why are researchers excited about this trial?
Researchers are excited about the Virtual Intensive Outpatient Program for alcoholism because it offers a fresh approach to treatment by being entirely virtual, making it more accessible to people who may have difficulty attending in-person sessions. Unlike traditional methods, which often require physical attendance at treatment centers, this program allows participants to receive daily psychotherapy, weekly individual therapy, and medication management right from home. Additionally, the program includes daily breathalyzer monitoring, offering real-time accountability and support. This innovative combination of virtual delivery and consistent monitoring could potentially enhance engagement and outcomes for individuals struggling with alcoholism.
What evidence suggests that this Virtual Intensive Outpatient Program is effective for alcohol use disorder?
Research has shown that intensive outpatient programs (IOPs) are as effective as inpatient treatments for many individuals with alcohol use problems. Studies have found that virtual IOPs, like the one in this trial, can be highly effective. They offer convenience and accessibility while providing structured support. Early results suggest these programs help individuals maintain sobriety through regular therapy and check-ins. Participants in this trial will receive a virtual program that includes daily group therapy, weekly one-on-one sessions, and medication management, all proven to aid in addiction treatment.13678
Who Is on the Research Team?
Matthew Sloan, MD
Principal Investigator
Centre for Addiction and Mental Health
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 with moderate to severe alcohol use disorder who are motivated to abstain from alcohol. Participants must attend daily virtual sessions on weekdays and take multiple breathalyzer readings each day. They need private space and OHIP coverage but can't join if they have a history of severe withdrawal, certain medical or psychiatric conditions, concurrent substance use disorders, or plans to be out of the province.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 4-week virtual intensive outpatient program with daily psychotherapy groups, weekly individual therapy, medication management, and daily breathalyzer monitoring.
Follow-up
Participants are monitored for safety and effectiveness after treatment with an on-site end of treatment visit and two follow-up visits at approximately day 30 and day 60.
Aftercare
Participants may opt into an optional weekly aftercare group for approximately 2 months after completion of the virtual IOP.
Long-term Follow-up
Participants can complete optional follow-up sessions every 2 months for an additional 10 months following the end of the 60-day follow-up session.
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Intensive Outpatient Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre for Addiction and Mental Health
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator